Drug intelligence / Profile preview

ru360

Development stage
Preclinical
Modality
Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
Administration
Intravenous (in Animal Studies), Intraperitoneal (in Animal Studies)
01

Overview

Ru360 (ruthenium-360) is a cell-permeable, oxygen-bridged dinuclear ruthenium ammine complex that acts as a highly selective inhibitor of the mitochondrial calcium uniporter (MCU). It binds to mitochondria with high affinity and potently blocks Ca2+ uptake into mitochondria in vitro and in situ. Ru360 does not significantly affect other cellular calcium transport processes at micromolar concentrations. Its mechanism of action involves preventing mitochondrial calcium overload by inhibiting MCU-mediated Ca2+ entry, thereby protecting against conditions such as myocardial reperfusion injury, liver steatosis induced by high-fat diet, and postoperative cognitive dysfunction. Ru360 has been studied for its protective effects on cardiac tissue during ischemia-reperfusion injury and for neuroprotection in models of brain injury or cognitive impairment[1][3][6][8][10].

Other names
ruthenium-360ruthenium360ruthenium 360ru 360ru360ru-360
02

Targets

MCU (Mitochondrial calcium uniporter)

Beyond the preview

Go deeper on ru360.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ru360.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call